Compare3 funds · 3 pairs
Picked · 3YTD
Every pair · 3Won · shared
Close to theseFee · YTD
Best of the threeNov 5
  • Lowest cost$ a year on $10kSCHD 0.06%
  • Most incometrailing 12-month yieldSCHD 2.98%
  • Best 5 yearsper yearVGT +15.4%
  • Smallest drop · 1Yworst fall in the past yearSCHD −6.9%
Measures won1–5SCHD wins · of 6 · 5Y
$10,000 · 5Y$20,466VGT · SCHD $16,375
Lowest cost0.06%SCHD · $6 on $10k
Most income2.98%SCHD · $298 on $10k
Smallest drop−6.9%SCHD · worst fall in 1Y
Held in common0.0%BBC and SCHD

BBC vs SCHD

5Y
BBC
SCHD
Virtus Biotech Clinical Trials ETF · $34MSchwab U.S. Dividend Equity ETF · $120B
+33.0%3 years · per year$23,503 · $17,414+20.3%
−1.3%5 years · per year$9,380 · $16,375+10.4%
0.65%Expense ratio$65 · $6 on $10k · lower wins0.06%
1.61%12-mo yield$161 · $298 on $10k2.98%
−30.2%Worst dropSmaller wins−6.9%
38.2%VolatilityLower wins11.7%
1–5SCHD wins
$10,000 · 5 yearsAll three, one scale
$10k startVGT $20.5kSCHD $16.4kBBC $9.4kOct 2021Nov 2026
Shared top holdingsBBC · SCHD

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%
End-of-day Nov 5, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

All Three

5Y3 funds
#Trend
1VGTVanguard Information Technology ETFReadDesk0.09%0.44%−7.3%+14.0%+11.1%+28.8%+15.4%−17.5%$154.5B
2BSCHDSchwab U.S. Dividend Equity ETFReadDesk0.06%2.98%−2.2%+32.3%+38.7%+20.3%+10.4%−6.9%$120.5B
3ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.61%−6.6%+5.6%+36.3%+33.0%−1.3%−30.2%$34M
End-of-day Nov 5, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs SCHD

5Y
Virtus Biotech Clinical Trials
$9,381
Schwab U.S. Dividend Equity
$16,375
$5k$10k$15kNov 2021Nov 2026$9,381$16,375$5k$10k$15kNov 2021Nov 2026$9,381$16,375
MeasureBBCSCHD
Fee0.65%0.06%
Cost on $10k a year$65$6
Yield1.61%2.98%
5 years, per year−1.3%+10.4%
3 years, per year+33.0%+20.3%
Worst drop · 1Y−30.2%−6.9%
Volatility · 1Y38.2%11.7%
5–1measures won
SCHD first
0.0%
holdings shared
Nov 5, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+32.3%
VIGVanguard
+12.5%
Jan 1Nov 5+32.3%+12.5%
+32.3%Year to date+12.5%
3.0%Yield1.5%
$120BAssets$109B
2–0SCHD wins
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

XLK vs VGT

YTD
SPDRXLK
+13.2%
VGTVanguard
+14.0%
Jan 1Nov 5+13.2%+14.0%
+13.2%Year to date+14.0%
0.08% · $8Fee · on $10k a year0.09% · $9
$117BAssets$155B
1–1level
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+8.5%
JEPIJ.P. Morgan
+5.2%
Jan 1Nov 5+8.5%+5.2%
+8.5%Year to date+5.2%
12.2%Yield8.1%
$42.6BAssets$46.8B
2–0JEPQ wins
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, SCHD, VGT

Today
2.2%most shared, SCHD and VGT
BBCSCHDVGT
BBC—0.0%0.0%
SCHD0.0%—2.2%
VGT0.0%2.2%—
End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$292most kept, SCHD
SCHD$298 − $6 = $292
BBC$161 − $65 = $96
VGT$44 − $9 = $35
KeptFee
End-of-day Nov 5, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com